SNDX

Syndax Pharmaceuticals Inc

Jun 05 • 04:00PM ET

17.34

-0.68 -3.77 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS TNGX CGON KYMR NUVL RYTM BMRN INCY KRYS AXSM

| Held by: VTI XBI IWM VXF IWO IBB VTWO SCHA VHT FYC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.80	Insider Own	9.24%	Shs Outstand	88.54M	Perf Week	-11.49%
Market Cap	1.54B	Forward P/E	-	EPS next Y	-0.59	Insider Trans	-0.46%	Shs Float	80.42M	Perf Month	-16.03%
Enterprise Value	1.53B	PEG	-	EPS next Q	-0.48	Inst Own	106.03%	Short Float	27.00%	Perf Quarter	-21.43%
Income	-243.25M	P/S	7.07	EPS this Y	45.70%	Inst Trans	-1.23%	Short Ratio	13.16	Perf Half Y	-12.02%
Sales	217.42M	P/B	36.89	EPS next Y	67.12%	ROA	-43.70%	Short Interest	21.71M	Perf YTD	-17.47%
Book/sh	0.47	P/C	4.36	EPS next 5Y	-	ROE	-189.53%	52W High	25.59 -32.24%	Perf Year	55.38%
Cash/sh	3.97	P/FCF	-	EPS past 3/5Y	-10.26% -12.05%	ROIC	-62.94%	52W Low	8.59 101.98%	Perf 3Y	-17.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 157.68%	Gross Margin	95.99%	Volatility	5.25% 4.65%	Perf 5Y	-2.86%
Dividend TTM	-	EV/Sales	7.04	EPS Y/Y TTM	27.68%	Oper. Margin	-102.81%	ATR (14)	0.93	Perf 10Y	31.36%
Dividend Ex-Date	-	Quick Ratio	5.06	Sales Y/Y TTM	397.28%	Profit Margin	-111.88%	RSI (14)	27.35	Recom	1.08
Dividend Gr. 3/5Y	- -	Current Ratio	5.47	EPS Q/Q	50.89%	SMA20	-11.83%	Beta	0.40	Target Price	39.25
Payout	-	Debt/Eq	8.30	Sales Q/Q	223.64%	SMA50	-19.44%	Rel Volume	1.64	Prev Close	18.02
Employees	298	LT Debt/Eq	8.29	Earnings	Apr 30 AMC	SMA200	-10.62%	Avg Volume	1.65M	Price	17.34
IPO	Mar 03, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.03% -7.02%	Trades		Volume	2,702,322	Change	-3.77%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)